CC
EW icon

Centiva Capital’s Edwards Lifesciences EW Stock Holding History

Centiva Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,000
Closed -$413K – 1441
2022
Q3 		$413K Buy
+5,000
New +$481K 0.01% 940
2019
Q4 		– Sell
-7,800
Closed -$572K – 841
2019
Q3 		$572K Buy
+7,800
New +$548K 0.04% 299

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Centiva Capital's EW Position: Q2 2026 in Review

Centiva Capital opened a new position in Edwards Lifesciences (EW) in Q2 2026: 9,122 shares worth $825K. The stake represents 0.01% of the portfolio and ranks #706 among its holdings. This is a return to the name: Centiva Capital previously reported a position in EW as recently as Q2 2025.

Centiva Capital first reported a position in EW in Q2 2019 and has held it in 15 quarters since. The position peaked at $1.87M in Q1 2024. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Centiva Capital held 9,122 shares of Edwards Lifesciences worth $825K as of Q2 2026.
  • Edwards Lifesciences was a new Centiva Capital position in Q2 2026.
  • Edwards Lifesciences made up 0.01% of Centiva Capital's portfolio in Q2 2026, its #706 holding.
  • Centiva Capital first reported a position in Edwards Lifesciences in Q2 2019 and has held it in 15 quarters since.
  • Centiva Capital's Edwards Lifesciences position peaked at $1.87M in Q1 2024.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.